Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 4515-4521, December 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiala, E. S.
Right arrow Articles by Weisburger, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiala, E. S.
Right arrow Articles by Weisburger, J. H.

Inhibition of the Metabolism of the Colon Carcinogen, Azoxymethane, by Pyrazole1

Emerich S. Fiala2, Callie Kulakis, Gail Christiansen and John H. Weisburger

Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595

Alterations of [14C]azoxymethane metabolism by pretreatment with pyrazole, an inhibitor of alcohol dehydrogenase, were studied in male F344 rats. Whereas control animals exhaled approximately 36% of the [14C]azoxymethane dose (10.5 mg/kg) in 6 hr as 14CO2, rats pretreated with pyrazole (40 mg/kg) exhaled approximately 3.5%. Pretreatment with pyrazole (360 mg/kg) caused a complete inhibition of exhaled 14CO2 for at least 6 hr. After 48 hr the amount of exhaled 14CO2 comprised approximately 50% of the dose in the controls, and 26 and 20% for the 40- and 360-mg/kg pyrazole-pretreated rats, respectively. [14C]Methylamine, [14C]urea, and [14C]methylazoxymethanol were detected in the urines of control rats. Pretreatment with pyrazole (40 mg/kg) caused a 2.5-fold increase in urinary methylazoxymethanol; pretreatment with pyrazole (360 mg/kg) increased the urinary level of azoxymethane some 2.5- to 3-fold. In contrast to controls and 40-mg/kg pyrazole-pretreated rats, 360-mg/kg pyrazole-pretreated animals showed increased urinary excretion of [14C]methylamine and continued excretion of [14C]methylazoxymethanol and unmetabolized [14C]azoxymethane during the 24- to 48-hr period after [14C]azoxymethane administration. Washed liver microsomes from pyrazole-treated rats converted azoxymethane to methylazoxymethanol at the same rate as controls, but the hydroxylation could be inhibited by the addition of pyrazole to the incubation system.

These results show that pyrazole inhibits the metabolism of azoxymethane at at least two steps. At 40 mg/kg, pyrazole inhibits the oxidation of methylazoxymethanol, presumably by blocking alcohol dehydrogenase. At 360 mg/kg, pyrazole blocks this reaction and inhibits the hydroxylation of azoxymethane.

1 This work was supported in part by Grant CA 15400 from the National Cancer Institute through the National Large Bowel Cancer Project and by Contract N01 CP 75948 with the National Cancer Institute.

2 To whom requests for reprints should be addressed.

Received 6/26/78. Accepted 8/30/78.




This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H. Chung, D. Wu, R. Gay, S. N. Han, B. Goldin, R. Bronson, J. Mason, D. E. Smith, and S. N. Meydani
Effect of Age on Susceptibility to Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation in C57BL/6JNIA Mice
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2003; 58(5): B400 - 405.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. K. Wali, D. Stoiber, L. Nguyen, J. Hart, M. D. Sitrin, T. Brasitus, and M. Bissonnette
Ursodeoxycholic Acid Inhibits the Initiation and Postinitiation Phases of Azoxymethane-induced Colonic Tumor Development
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1316 - 1321.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Koesters, M. A. Hans, A. Benner, R. Prosst, J. Boehm, J. Gahlen, and M. von Knebel Doeberitz
Predominant mutation of codon 41 of the {beta}-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol
Carcinogenesis, November 1, 2001; 22(11): 1885 - 1890.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.